V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280011810 | 280004320 | 1.69 | null | Palliative (P) | 2017-02-02 | 2017-02-03 | Trial Unspecified | 02 | null | 280009683 | TRIAL |
| 280011811 | 280008352 | 1.64 | 49.7 | Curative (C) | 2013-07-23 | 2013-08-12 | CISPLATIN + RT | 02 | N | 280011597 | CISPLATIN + RT |
| 280011812 | 280004400 | 1.87 | 82.9 | Palliative (P) | 2018-10-27 | 2018-10-27 | Trabectedin | 02 | N | 280011722 | TRABECTEDIN |
| 280011813 | 280004444 | null | 60.9 | Palliative (P) | 2019-07-05 | 2019-08-26 | Trabectedin | N | Y | 280012488 | TRABECTEDIN |
| 280011814 | 280004520 | 1.81 | 71.4 | Curative (C) | 2018-12-28 | 2019-02-22 | Cisplatin + Radiotherapy | 02 | null | 280014095 | CISPLATIN + RT |
| 280011815 | 280004612 | 1.65 | 61.3 | Curative (C) | 2014-10-02 | 2014-11-11 | Cisplatin 100 + RT(H&N) 1 day | Y | N | 280024089 | CISPLATIN + RT |
| 280011816 | 280004622 | 1.88 | 74.1 | Adjuvant (A) | 2019-03-16 | 2019-04-20 | CISPLATIN + RT | 2 | N | 280024146 | CISPLATIN + RT |
| 280011817 | 280004696 | 1.75 | 56.6 | Curative (C) | 2016-10-12 | 2016-11-09 | EW EuroEwing 2012 Arm B VDC | Y | null | 280024558 | TRIAL |
| 280011818 | 280004708 | 1.65 | 88.6 | Neo-adjuvant (N) | 2016-10-01 | 2017-02-24 | EW EuroEwing 2012 Arm B VDC | N | y | 280024610 | TRIAL |
| 280011819 | 280004723 | null | 92.3 | Curative (C) | 2018-05-19 | 2018-07-07 | Cisplatin + Radiotherapy | 02 | Y | 280024637 | CISPLATIN + RT |
| 280011820 | 280004728 | 1.48 | 88.6 | Curative (C) | null | 2015-06-24 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 280024659 | CISPLATIN + RT |
| 280011821 | 280004787 | 1.71 | 106 | Curative (C) | 2016-12-13 | 2017-02-08 | CISPLATIN + RT | 02 | Y | 280024821 | CISPLATIN + RT |
| 280011822 | 280004794 | 1.82 | 52 | Curative (C) | null | 2018-05-10 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 280024836 | CISPLATIN + RT |
| 280011823 | 280008550 | 1.68 | 59 | Disease modification (D) | 2017-09-11 | 2017-09-16 | Trial Unspecified | Y | N | 280024866 | TRIAL |
| 280011824 | 280004814 | 1.5 | null | Curative (C) | 2014-06-21 | 2014-06-21 | Cisplatin + Radiotherapy | 02 | Y | 280024885 | CISPLATIN + RT |
| 280011825 | 280004819 | 1.65 | null | Curative (C) | null | 2016-10-17 | Cisplatin + Radiotherapy | N | Y | 280024894 | CISPLATIN + RT |
| 280011826 | 280004822 | 1.68 | 111 | Curative (C) | null | 2018-07-05 | Cisplatin + Radiotherapy | 2 | N | 280024896 | CISPLATIN + RT |
| 280011827 | 280004838 | 1.68 | 77.2 | null | null | 2015-10-11 | Trabectedin | N | N | 280024927 | TRABECTEDIN |
| 280011828 | 280004857 | 0 | 76.1 | Neo-adjuvant (N) | 2016-11-11 | 2016-11-13 | Trial Unspecified | 02 | N | 280024952 | TRIAL |
| 280011829 | 280004866 | 1.64 | 84 | Palliative (P) | 2016-05-28 | 2016-05-28 | Trial Unspecified | null | null | 280024975 | TRIAL |
| 280011830 | 280004872 | 1.8 | 92 | null | 2017-08-12 | 2018-08-08 | CISPLATIN + RT | 02 | Y | 280024990 | CISPLATIN + RT |
| 280011831 | 280004882 | 1.75 | 96 | Palliative (P) | 2016-05-03 | 2016-08-13 | Cetuximab 7 day (>Cycle 2) | 02 | N | 280025025 | CETUXIMAB |
| 280011832 | 280008597 | 1.52 | 57 | Palliative (P) | 2016-02-08 | 2016-02-14 | EW EuroEwing 2012 Arm B VC | Y | N | 280025083 | NOT MATCHED |
| 280011833 | 280004905 | null | 81.6 | Palliative (P) | 2015-07-26 | 2015-09-07 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 99 | N | 280025097 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280011834 | 280008603 | null | 85 | Neo-adjuvant (N) | 2015-06-16 | 2015-11-29 | EW EuroEwing 2012 Arm B VC | N | Y | 280025130 | NOT MATCHED |
| 280011835 | 280004920 | null | 19.9 | Curative (C) | 2015-11-21 | 2015-12-24 | Carboplatin AUC 2 - 5 | N | null | 280025156 | CARBOPLATIN |
| 280011836 | 280004929 | 1.61 | 73.2 | Palliative (P) | 2016-06-12 | 2016-07-09 | Carboplatin AUC 2 - 5 | 02 | N | 280025171 | CARBOPLATIN |
| 280011837 | 280008611 | 1.91 | null | Curative (C) | 2016-12-28 | 2017-01-28 | Cetuximab 7 day (Cycle 1) | Y | null | 280025182 | CETUXIMAB |
| 280011838 | 280008612 | 0 | 82.6 | Neo-adjuvant (N) | 2012-08-09 | 2014-08-15 | NB HRNBL-1 COJEC Ind COURSE B | null | null | 280025184 | NOT MATCHED |
| 280011839 | 280004938 | 0 | 58.7 | Palliative (P) | 2012-08-30 | 2014-02-17 | STS Rhabdo VIT0910 Vinc Irino Temoz | 02 | null | 280025187 | NOT MATCHED |
| 280011840 | 280004945 | 1.86 | 18 | Neo-adjuvant (N) | 2015-12-08 | 2015-12-08 | Docetaxel + Gemcitabine (prior RT) | N | N | 280025201 | DOCETAXEL + GEMCITABINE |
| 280011841 | 280004959 | 1.76 | 96.2 | Curative (C) | 2016-05-11 | 2016-06-04 | Carboplatin AUC 2 - 5 | 02 | null | 280025240 | CARBOPLATIN |
| 280011842 | 280004965 | 1.82 | 51.3 | Palliative (P) | 2013-10-31 | 2013-11-01 | Carboplatin AUC 6 - 10 | N | N | 280025260 | CARBOPLATIN |
| 280011843 | 280004983 | null | 0 | Neo-adjuvant (N) | 2017-02-18 | 2017-02-25 | Cetuximab 7 day (>Cycle 2) | N | N | 280025300 | CETUXIMAB |
| 280011844 | 280004993 | 1.92 | null | Palliative (P) | 2018-04-19 | 2018-04-19 | DOCETAXEL + GEMCITABINE | N | N | 280025357 | DOCETAXEL + GEMCITABINE |
| 280011845 | 280004994 | 1.59 | null | Curative (C) | 2015-08-05 | 2015-08-13 | Carboplatin AUC 2 - 5 | 02 | null | 280025359 | CARBOPLATIN |
| 280011846 | 280005030 | 1.76 | 53.1 | Curative (C) | 2017-07-06 | 2017-07-11 | Carboplatin AUC 2 - 5 | null | N | 280025427 | CARBOPLATIN |
| 280011847 | 280005043 | 1.65 | 82 | Palliative (P) | 2018-02-03 | 2018-02-03 | Carboplatin AUC 2 - 5 | N | N | 280025459 | CARBOPLATIN |
| 280011848 | 280008676 | null | null | Palliative (P) | 2017-01-02 | 2017-02-05 | Carboplatin AUC 6 - 10 | 01 | N | 280025512 | CARBOPLATIN |
| 280011849 | 280010410 | null | 78 | Neo-adjuvant (N) | 2019-06-26 | 2019-06-26 | Carboplatin AUC 2 - 5 | N | N | 280025551 | CARBOPLATIN |
| 280011851 | 280005101 | null | 47.3 | Palliative (P) | null | 2016-12-12 | Olaratumab | N | null | 280025588 | NOT MATCHED |
| 280011852 | 280005123 | null | 78.5 | Palliative (P) | 2017-01-16 | 2017-02-01 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | N | 280025635 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280011853 | 280010427 | 1.8 | null | Neo-adjuvant (N) | 2013-04-07 | 2013-04-07 | Carboplatin AUC 6 - 10 | Y | N | 280025646 | CARBOPLATIN |
| 280011854 | 280005151 | 1.77 | 65.6 | Neo-adjuvant (N) | 2018-03-12 | 2018-03-22 | Docetaxel+Gemcitabine (no prior RT) | 02 | Y | 280025728 | DOCETAXEL + GEMCITABINE |
| 280011855 | 280008728 | null | 83.2 | Neo-adjuvant (N) | 2017-08-29 | 2017-10-17 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025749 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280011856 | 280005179 | 1.65 | null | Palliative (P) | 2017-10-14 | 2017-10-19 | Cetuximab 7 day (>Cycle 2) | 2 | N | 280025794 | CETUXIMAB |
| 280011857 | 280008757 | 1.62 | 60.9 | Adjuvant (A) | 2014-05-09 | 2014-07-14 | Carboplatin AUC 2 - 5 | 01 | N | 280025900 | CARBOPLATIN |
| 280011858 | 280005266 | 0 | null | Palliative (P) | 2018-11-12 | 2018-11-12 | EW Rel rEECur Gemcitabine/Docetaxel | null | N | 280026065 | NOT MATCHED |
| 280011859 | 280005346 | 1.7 | null | Palliative (P) | 2017-11-26 | 2018-01-26 | CETUXIMAB | N | null | 280026313 | CETUXIMAB |
| 280011860 | 280005412 | 1.73 | null | Disease modification (D) | 2015-02-27 | 2015-02-27 | Ifosfamide | N | N | 280026704 | IFOSFAMIDE |